SBIR/STTR Research Award

An Acoustofluidic Device for Point-of-Care Sputum Processing and Analysis

Award identifier 2d7500a3aa4b6c73201c0b121a832f1a29d1ac78356839b9ff14ed4a20643065Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$225,000

Program and phase

SBIR · Phase I

Award year

2015

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Ascent Bio-Nano Technologies Inc
Proposal award date
2014-12-01
Contract end date
2015-05-31
UEI
H8AQL3HN4PM8
Solicitation number
HL14-011
Topic code
NHLBI

Research abstract

DESCRIPTION provided by applicant Asthma is a chronic lung disease that causes the airways in the lungs to become inflamed making it difficult to breathe and leading to episodes of intense coughing and wheezing Frequently the symptoms of asthma require hospitalization for treatment and in rare cases can lead to death Unfortunately the prevalence of asthma has increased rapidly over the past several decades and more than in Americans are now living with the disease While there is no cure for asthma the symptoms of the disease can be managed through a series of prescription medicines However this conventional one size fits all therapeutic approach fails to account for the different clinical forms and phenotypes of asthma which have been the subject of many recent medical studies By analyzing the different cell populations found in sputum the mucus within the airways of the lungs researchers have identified the distinct immunological phenotypes associated with the disease Identifying these phenotypes has led to hopes of developing individually tailored therapeutic treatments that will more effectively target the mechanisms unique to each phenotype Although sputum analysis has proven to be a powerful tool that provides a noninvasive means of characterizing the different variations of asthma the current methods for processing and analyzing sputum are complex and labor intensive The multi step process requires highly trained personnel and the amount of sputum collected from a patient is often too small to perform meaningful analysis In addition the process requires the use of expensive benchtop equipment which prevents point of care applications and limits the analysis to centralized facilities As a result there exists a critical need in the medical community for a more simple and rapid approach for processing and analyzing low volume sputum samples Recently we have developed a series of acoustofluidic i e fusion of acoustics and microfluidics technologies which collectively perform the necessary functions for sputum processing and analysis We have demonstrated the first sharp edge based acoustofluidic mixer the first surface acoustic wave SAW based cell separator and the first SAW focusing microflow cytometer Our goal is to demonstrate the ability of each acoustofluidic based technique to perform its function in relation to the processing and analyzing low volume sputum samples Specifically we will develop and characterize an acoustofluidic sputum liquefying unit develop an acoustofluidic unit for the on chip transfer of immune cells from liquefied sputum sample to phosphate buffered saline PBS and demonstrate an acoustofluidic flow cytometry unit that accurately analyzes immune cells from induced sputum samples In each aim we will compare the results obtained from our acoustofluidic units to those obtained by their conventional counterparts Our long term goal is to integrate the three acoustofluidic units to develop an easy to use point of care device We believe advances in this area will be critical in the development of personalized treatments for asthma and may also find use in monitoring and treating other respiratory diseases and infections PUBLIC HEALTH RELEVANCE The proposed project is to develop tools that can perform point of care sputum processing and analysis from low volume samples Advances achieved in the proposed project will be critical in the development of personalized treatments for asthma End of Abstract

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

13 SBIR/STTR records share this UEI (2014–2024). Reported award amounts total $15,607,704. Reported amounts are not federal obligations.

Phases: Phase II, Phase I, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.